TY - JOUR
T1 - Defining the causes of sporadic Parkinson's disease in the global Parkinson's genetics program (GP2)
AU - Global Parkinson’s Genetics Program (GP2)
AU - Towns, Clodagh
AU - Richer, Madeleine
AU - Jasaityte, Simona
AU - Stafford, Eleanor J
AU - Joubert, Julie
AU - Antar, Tarek
AU - Martinez-Carrasco, Alejandro
AU - Makarious, Mary B
AU - Casey, Bradford
AU - Vitale, Dan
AU - Levine, Kristin
AU - Leonard, Hampton
AU - Pantazis, Caroline B
AU - Screven, Laurel A
AU - Hernandez, Dena G
AU - Wegel, Claire E
AU - Solle, Justin
AU - Nalls, Mike A
AU - Blauwendraat, Cornelis
AU - Singleton, Andrew B
AU - Tan, Manuela M X
AU - Iwaki, Hirotaka
AU - Morris, Huw R
N1 - © 2023. Springer Nature Limited.
PY - 2023/9/12
Y1 - 2023/9/12
N2 - The Global Parkinson's Genetics Program (GP2) will genotype over 150,000 participants from around the world, and integrate genetic and clinical data for use in large-scale analyses to dramatically expand our understanding of the genetic architecture of PD. This report details the workflow for cohort integration into the complex arm of GP2, and together with our outline of the monogenic hub in a companion paper, provides a generalizable blueprint for establishing large scale collaborative research consortia.
AB - The Global Parkinson's Genetics Program (GP2) will genotype over 150,000 participants from around the world, and integrate genetic and clinical data for use in large-scale analyses to dramatically expand our understanding of the genetic architecture of PD. This report details the workflow for cohort integration into the complex arm of GP2, and together with our outline of the monogenic hub in a companion paper, provides a generalizable blueprint for establishing large scale collaborative research consortia.
U2 - 10.1038/s41531-023-00533-w
DO - 10.1038/s41531-023-00533-w
M3 - Journal articles
C2 - 37699923
SN - 2373-8057
VL - 9
SP - 131
JO - NPJ Parkinson's disease
JF - NPJ Parkinson's disease
IS - 1
ER -